BC-007(Mohua (Wuxi) Biotech)

N/A

Report date: 2024/06/18 16:38:30
NME

Base Information

Drug NameBC-007(Mohua (Wuxi) Biotech)
Drug Alias NameBC-007BC007
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies默化（无锡）生物科技有限公司
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active Companies默化（无锡）生物科技有限公司
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A